Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vincent Meininger
Jeremy Shefner
Merit Cudkowicz

Showing results (21-30 of 292) with videos related to

Pageof 30
Sort By:
Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders : Official Publication of the World Federation of Neurology, Research Group on Motor Neuron Diseases|October 30, 2004
Maximum voluntary isometric contraction (MVIC)Merit Cudkowicz, Hui Zhang, Muhammad Qureshi, et al.
Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders : Official Publication of the World Federation of Neurology, Research Group on Motor Neuron Diseases|October 30, 2004
European ALS ConsortiumVincent Meininger
Neuro-Degenerative Diseases|August 16, 2006
Clinical trials in ALS: what did we learn from recent trials in humans?Vincent Meininger
Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders : Official Publication of the World Federation of Neurology, Research Group on Motor Neuron Diseases|October 25, 2002
Survival endpoint: summaryVincent Meininger
Archives Italiennes De Biologie|March 18, 2011
ALS, what new 144 years after Charcot?Vincent Meininger
The Lancet. Neurology|January 25, 2005
Treatment of emotional lability in ALSVincent Meininger
Physical Medicine and Rehabilitation Clinics of North America|November 27, 2012
Electrodiagnosis of motor neuron diseaseAnuradha Duleep, Jeremy Shefner
Amyotrophic Lateral Sclerosis : Official Publication of the World Federation of Neurology Research Group on Motor Neuron Diseases|July 9, 2008
Thrombopoietin is ineffective in a mouse model of motor neuron diseaseAndrew Caraganis, Susanna Benn, Merit Cudkowicz, et al.
Neurology. Clinical Practice|September 3, 2021
Radicava/Edaravone Findings in Biomarkers From Amyotrophic Lateral Sclerosis (REFINE-ALS): Protocol and Study DesignJames Berry, Benjamin Brooks, Angela Genge, et al.
Nature Medicine|November 22, 2011
The effects of dexpramipexole (KNS-760704) in individuals with amyotrophic lateral sclerosisMerit Cudkowicz, Michael E Bozik, Evan W Ingersoll, et al.
Pageof 30

Showing results (21-30 of 292) with videos related to

Sort By:
Pageof 30
Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders : Official Publication of the World Federation of Neurology, Research Group on Motor Neuron Diseases|October 30, 2004
Maximum voluntary isometric contraction (MVIC)Merit Cudkowicz, Hui Zhang, Muhammad Qureshi, et al.
Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders : Official Publication of the World Federation of Neurology, Research Group on Motor Neuron Diseases|October 30, 2004
European ALS ConsortiumVincent Meininger
Neuro-Degenerative Diseases|August 16, 2006
Clinical trials in ALS: what did we learn from recent trials in humans?Vincent Meininger
Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders : Official Publication of the World Federation of Neurology, Research Group on Motor Neuron Diseases|October 25, 2002
Survival endpoint: summaryVincent Meininger
Archives Italiennes De Biologie|March 18, 2011
ALS, what new 144 years after Charcot?Vincent Meininger
The Lancet. Neurology|January 25, 2005
Treatment of emotional lability in ALSVincent Meininger
Physical Medicine and Rehabilitation Clinics of North America|November 27, 2012
Electrodiagnosis of motor neuron diseaseAnuradha Duleep, Jeremy Shefner
Amyotrophic Lateral Sclerosis : Official Publication of the World Federation of Neurology Research Group on Motor Neuron Diseases|July 9, 2008
Thrombopoietin is ineffective in a mouse model of motor neuron diseaseAndrew Caraganis, Susanna Benn, Merit Cudkowicz, et al.
Neurology. Clinical Practice|September 3, 2021
Radicava/Edaravone Findings in Biomarkers From Amyotrophic Lateral Sclerosis (REFINE-ALS): Protocol and Study DesignJames Berry, Benjamin Brooks, Angela Genge, et al.
Nature Medicine|November 22, 2011
The effects of dexpramipexole (KNS-760704) in individuals with amyotrophic lateral sclerosisMerit Cudkowicz, Michael E Bozik, Evan W Ingersoll, et al.
Pageof 30